|
Volumn 27, Issue 4, 2007, Pages 22-32
|
"Offshoring" life science production is not the only answer
f
PICME
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMEDICINE;
COMMERCIAL PHENOMENA;
COST BENEFIT ANALYSIS;
DRUG INDUSTRY;
DRUG MARKETING;
MATERIALS;
PHARMACEUTICAL ENGINEERING;
QUALITY CONTROL;
REVIEW;
|
EID: 34547754479
PISSN: 02738139
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (10)
|